vs
Business First Bancshares, Inc.（BFST）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Business First Bancshares, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$83.1M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 7.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 16.8%）
第一公民银行股份公司是一家银行控股公司，总部位于美国北卡罗来纳州罗利，是美国规模最大的银行机构之一。公司核心子公司第一公民银行在全美23个州经营着超过500家网点，另一子公司硅谷银行则在15个州设有39家办事处。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BFST vs RIGL — 直观对比
营收规模更大
BFST
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出14.1%
7.1%
两年增速更快
RIGL
近两年复合增速
16.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $83.1M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 33.2% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 7.1% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.71 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BFSTRIGL
| Q4 25 | $83.1M | $69.8M | ||
| Q3 25 | $80.9M | $69.5M | ||
| Q2 25 | $81.5M | $101.7M | ||
| Q1 25 | $79.2M | $53.3M | ||
| Q4 24 | $77.6M | $57.6M | ||
| Q3 24 | $66.9M | $55.3M | ||
| Q2 24 | $66.2M | $36.8M | ||
| Q1 24 | $60.9M | $29.5M |
净利润BFSTRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $22.9M | $27.9M | ||
| Q2 25 | $22.1M | $59.6M | ||
| Q1 25 | $20.5M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $17.8M | $12.4M | ||
| Q2 24 | $17.2M | $-1.0M | ||
| Q1 24 | $13.6M | $-8.2M |
毛利率BFSTRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率BFSTRIGL
| Q4 25 | 33.2% | 33.2% | ||
| Q3 25 | 35.7% | 40.9% | ||
| Q2 25 | 34.4% | 60.1% | ||
| Q1 25 | 32.6% | 23.9% | ||
| Q4 24 | 27.5% | 28.9% | ||
| Q3 24 | 34.0% | 25.4% | ||
| Q2 24 | 32.9% | 1.2% | ||
| Q1 24 | 28.2% | -23.6% |
净利率BFSTRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 28.2% | 40.2% | ||
| Q2 25 | 27.1% | 58.6% | ||
| Q1 25 | 25.9% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 26.7% | 22.5% | ||
| Q2 24 | 26.0% | -2.8% | ||
| Q1 24 | 22.3% | -27.9% |
每股收益（稀释后）BFSTRIGL
| Q4 25 | $0.71 | $14.11 | ||
| Q3 25 | $0.73 | $1.46 | ||
| Q2 25 | $0.70 | $3.28 | ||
| Q1 25 | $0.65 | $0.63 | ||
| Q4 24 | $0.51 | $0.82 | ||
| Q3 24 | $0.65 | $0.70 | ||
| Q2 24 | $0.62 | $-0.06 | ||
| Q1 24 | $0.48 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $411.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $896.9M | $391.5M |
| 总资产 | $8.2B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BFSTRIGL
| Q4 25 | $411.2M | $155.0M | ||
| Q3 25 | $399.1M | $137.1M | ||
| Q2 25 | $495.8M | $108.4M | ||
| Q1 25 | $312.9M | $77.1M | ||
| Q4 24 | $319.1M | $77.3M | ||
| Q3 24 | $213.2M | $61.1M | ||
| Q2 24 | $208.1M | $49.1M | ||
| Q1 24 | $185.9M | $49.5M |
总债务BFSTRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益BFSTRIGL
| Q4 25 | $896.9M | $391.5M | ||
| Q3 25 | $878.4M | $117.6M | ||
| Q2 25 | $848.4M | $81.9M | ||
| Q1 25 | $826.3M | $18.6M | ||
| Q4 24 | $799.5M | $3.3M | ||
| Q3 24 | $699.5M | $-14.6M | ||
| Q2 24 | $664.5M | $-29.9M | ||
| Q1 24 | $649.0M | $-31.7M |
总资产BFSTRIGL
| Q4 25 | $8.2B | $513.6M | ||
| Q3 25 | $8.0B | $242.5M | ||
| Q2 25 | $7.9B | $206.7M | ||
| Q1 25 | $7.8B | $176.0M | ||
| Q4 24 | $7.9B | $164.0M | ||
| Q3 24 | $6.9B | $139.4M | ||
| Q2 24 | $6.7B | $128.4M | ||
| Q1 24 | $6.7B | $126.5M |
负债/权益比BFSTRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $92.1M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $92.0M | — |
| 自由现金流率自由现金流/营收 | 110.7% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $165.6M | — |
8季度趋势，按日历期对齐
经营现金流BFSTRIGL
| Q4 25 | $92.1M | $22.0M | ||
| Q3 25 | $32.4M | $24.0M | ||
| Q2 25 | $14.0M | $30.5M | ||
| Q1 25 | $28.7M | $-893.0K | ||
| Q4 24 | $61.4M | $14.5M | ||
| Q3 24 | $21.4M | $21.7M | ||
| Q2 24 | $15.1M | $302.0K | ||
| Q1 24 | $7.6M | $-5.0M |
自由现金流BFSTRIGL
| Q4 25 | $92.0M | — | ||
| Q3 25 | $32.1M | — | ||
| Q2 25 | $13.8M | — | ||
| Q1 25 | $27.7M | — | ||
| Q4 24 | $59.8M | — | ||
| Q3 24 | $21.0M | — | ||
| Q2 24 | $14.0M | — | ||
| Q1 24 | $7.2M | — |
自由现金流率BFSTRIGL
| Q4 25 | 110.7% | — | ||
| Q3 25 | 39.6% | — | ||
| Q2 25 | 16.9% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 77.1% | — | ||
| Q3 24 | 31.4% | — | ||
| Q2 24 | 21.2% | — | ||
| Q1 24 | 11.8% | — |
资本支出强度BFSTRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 0.6% | — |
现金转化率BFSTRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.42× | 0.86× | ||
| Q2 25 | 0.63× | 0.51× | ||
| Q1 25 | 1.40× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.20× | 1.75× | ||
| Q2 24 | 0.88× | — | ||
| Q1 24 | 0.56× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
